UPDATES ON CONVERSATION WITH THE COMPANY - I called them at 11:50 am CST and spoke to Armen for about 30 minutes. They've got some great stuff ready to PR!
1. Chicago Venture Loan
CV is all DONE!! ACTUALLY he said it was done LONG TIME AGO!! Total $280K loan, they paid $130K in cash, and $150K in shares. All have been cleared. He thought they already PRed this. I was like what the heck!! Guess they have been so freaking busy these days that they even forgot to PR this great news! Zero debt, nothing, zip left!!! He will tell Shital to get the PR out tomorrow or asap.
2. M&A
He said they will have some updates coming out very soon. I asked about M&A, he said there will be update on that. I said when, he laughed in a way that says everything. I feel we will see a PR on this probably in March.
3. CBD/Hemp Compounds
He personally has tested their R&D product and thought it really worked very well. They are now in talks with CBD manufacturers for future production need. They will have dedicated R&D department working on these products in house. He's very excited about the huge market needs for their product. The good thing is this does not have to be prescription drugs. It can be over the counter compounds which will make it much easier for them to sell these products.
4. VIOSS Partner for Telepharmacy
They posted on their FB couple weeks ago saying VIOSS could be a potential partner for their telepharmacy business. Currently, they are actively testing VIOSS kiosks and other platforms and comparing to some other suppliers' products. They will pick the best one as their final partner going forward. Their plan is to put up telepharm kiosks in every major community center and long-term care facility that they are working with right now. That's really huge expansion.
5. 2017 Audit
Everything is all good. The audit will be complete by the due date on 3/31/2018. They will PR immediately after the due date or even before that next month.
6. Institutional Investment / Traditional Bank Financing
Now with 2 years of audit and over $20M NET revenue, he said institutions are finally willing to invest in them. They definitely will seek traditional bank financing going forward for their expansions and more M&A needs!
RXMD is golden. This is a great company with great leaders. 2018 HAS BEEN and WILL be GREAT for us all!
News 
Market Data 
Discover 
